Has Elber Camacho received payments from drug or device companies?

Yes. Drug and device makers reported $15,371 in general payments to Elber Camacho across 291 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Elber Camacho did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Elber Camacho come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Elber Camacho

Hematology & Oncology · la Quinta, CANPI 1598761710

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $9,339 of the $15,371 with a category attached, or 60.8%. 59 manufacturers reported payments, led by AstraZeneca at 27.9% of the total. Reporting peaked in 2020 at $6,399 and has fallen 76.3% since, to $1,517 in 2025.

$15,371in general payments, 2019–2025

Across 291 payments — averaging $52.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AstraZeneca$4K
Gilead$2K
Epizyme, Inc.$2K
E.r. Squibb & Sons, L.L.C.$707
Johnson & Johnson$570
Merck$499
plus $6K from 53 others

$40,200in research payments, 2019–2025

Across 10 payments — averaging $4020.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Bristol Myers Squibb$33K
E.r. Squibb & Sons, L.L.C.$7K

What the payments were for

Consulting fees$4,38028%
Speaking & faculty fees$1,50010%
Food & beverage$9,33961%
Education$1521%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AstraZeneca	31	$4,287
Gilead(2 entities)	7	$1,686
Epizyme, Inc.	1	$1,500
E.r. Squibb & Sons, L.L.C.	41	$707
Johnson & Johnson(2 entities)	24	$570
Merck	16	$499
Regeneron Healthcare Solutions, Inc.	10	$458
Genentech USA, Inc.	8	$434
Amgen	10	$370
GSK	3	$350
Incyte Corporation	7	$293
Pfizer	8	$265
Novocure Inc.	2	$238
Sanofi	9	$237
Karyopharm Therapeutics Inc.	6	$227
Daiichi Sankyo Inc.	7	$204
AbbVie	9	$196
Novartis	4	$184
Pharmacyclics LLC, An Abbvie Company	4	$165
Eisai Inc.	7	$163
Galvanize Therapeutics, Inc	1	$158
Puma Biotechnology, Inc.	3	$154
Bayer	3	$150
Sobi, Inc	2	$149
Telix Pharmaceuticals	1	$147
Jazz Pharmaceuticals Inc.	2	$142
Secura Bio, Inc.	3	$130
Array Biopharma Inc	6	$106
Rigel Pharmaceuticals, Inc.	5	$101
Pharmaessentia USA Corporation	3	$89
Takeda Pharmaceuticals U.S.A., Inc.	3	$82
Bristol Myers Squibb	4	$72
Seagen Inc.	4	$69
Kyowa Kirin, Inc.	3	$61
Janssen Scientific Affairs, LLC	2	$61
Beone Medicines USA, Inc.	2	$54
EMD Serono, Inc.	2	$50
Boehringer Ingelheim	3	$43
EUSA Pharma (US) LLC	2	$42
AMAG Pharmaceuticals, Inc.	2	$41
Monteris Medical Corporation	2	$35
Coherus Oncology, Inc.	2	$35
Intuitive Surgical	1	$35
Taiho Oncology, Inc.	1	$33
Beigene USA, Inc.	1	$29
Springworks Therapeutics, Inc.	1	$26
Tolmar Pharmaceuticals, Inc.	1	$25
AVEO Pharmaceuticals, Inc.	1	$24
Exelixis Inc.	1	$22
Verastem, Inc.	1	$22
Abbott	1	$20
Mylan Institutional Inc.	1	$20
Blueprint Medicines Corporation	1	$19
Teva Pharmaceuticals USA, Inc.	1	$17
Helsinn Therapeutics (U.S.), Inc.	1	$17
Lilly USA, LLC	1	$16
Ipsen Biopharmaceuticals, Inc	1	$15
Dova Pharmaceuticals	1	$13
Servier Pharmaceuticals LLC	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$15,371 in reported general payments places this provider in the 70th percentile of 1,363 hematology & oncology providers in California.

See all hematology & oncology providers in California →

Other hematology & oncology in la Quinta

Dennis SlamonLos Angeles$3.1M
Sandra HorningStanford$2.5M
Mohammadbagher ZiariCorona$2.5M
George YaghmourLos Angeles$1.9M
Robert VescioWest Hollywood$1.1M
Kevin KellyLos Angeles$894K
Johnny ChangEncino$884K
Nitin RohatgiSacramento$814K
Omid HamidSanta Monica$809K
Catherine CoombsOrange$786K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →